author-photo

Tania Fleitas

University of Valencia

25

Papers

302

Citations

Citation Trend

Filter By

Papers (13) Sort By

Journal Conference Others

An Application of an EHR Based on Conceptual Modeling to Integrate Clinical and Genomic Data and Guide Therapeutic Strategy

2020
Show All
- Source
- Cite
- Save
Citations (0)
Understanding mechanisms of primary resistance to checkpoint inhibitors will lead to precision immunotherapy of advanced gastric cancer

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Towards precision oncology for anti-HER2 blockade in gastroesophageal adenocarcinoma

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (9)
PO-500 NRF2 represents a convergent point of acquired resistance in HER2 positive gastric cancer models

2018
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 4048: Comprehensive analysis of the suppressed tumor immune microenvironment of CIN gastro-esophageal adenocarcinomas

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Phase Ib study of lumretuzumab plus cetuximab or erlotinib in solid tumor patients and evaluation of HER3 and heregulin as potential biomarkers of clinical activity

2017 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (22)
Impact of tumor heregulin mRNA expression on outcome of patients with advanced/metastatic squamous NSCLC treated with lumretuzumab, a glycoengineered monoclonal antibody targeting HER3, in combination with erlotinib

2016 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
MassARRAY determination of somatic oncogenic mutations in solid tumors: Moving forward to personalized medicine

2016 Cancer Treatment Reviews
Show All
- Source
- Cite
- Save
Citations (8)
Neoadjuvant and combined chemoradiotherapy followed by surgery in locally advanced esophageal cancer: A single-centre experience

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A phase Ib study of lumretuzumab, a glycoengineered monoclonal antibody targeting HER3, in combination with carboplatin and paclitaxel as 1st-line treatment in patients with squamous non-small cell lung cancer

2016 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (2)